Sign Out
Selection of Patients: A thorough gynecologic and endocrine evaluation, including an assessment of pelvic anatomy must be performed before treatment with Menotrophin (Gynogen HP) patients with tubal obstruction should receive Menotrophin (Gynogen HP) only if enrolled in an IVF program.
Primary ovarian failure should be excluded by the determination of gonadotropin levels.
Careful examination should be made to rule out the presence of an early pregnancy.
Patients in late reproductive life have a greater predilection to endometrial carcinoma as well as a higher incidence of anovulatory disorders. A thorough diagnostic evaluation should always be performed in patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities before starting Menotrophin therapy.
Evaluation of the partner's fertility potential should be included in the work up.
Continue with Google